Pique Therapeutics' Series A Round

Pique Therapeutics raised a round of funding on June 12, 2009.

Pique Therapeutics is a biotechnology company focused initially on the treatment of cancer. Pique's lead product is a therapeutic vaccine for non-small cell lung cancer in Phase 2 clinical trials. Pi…

Articles about Pique Therapeutics' Series A Round: